Inflammation in diabetic nephropathy

AKH Lim, GH Tesch - Mediators of inflammation, 2012 - Wiley Online Library
Diabetic nephropathy is the leading cause of end‐stage kidney disease worldwide but
current treatments remain suboptimal. This review examines the evidence for inflammation …

Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets

R Pichler, M Afkarian, BP Dieter… - American Journal of …, 2017 - journals.physiology.org
Increasing incidences of obesity and diabetes have made diabetic kidney disease (DKD) the
leading cause of chronic kidney disease and end-stage renal disease worldwide. Despite …

Rodent models of neuroinflammation for Alzheimer's disease

A Nazem, R Sankowski, M Bacher… - Journal of …, 2015 - Springer
Alzheimer's disease remains incurable, and the failures of current disease-modifying
strategies for Alzheimer's disease could be attributed to a lack of in vivo models that …

Leukocyte recruitment and vascular injury in diabetic nephropathy

E Galkina, K Ley - Journal of the American Society of Nephrology, 2006 - journals.lww.com
Different types of activated leukocytes play a crucial role in the pathogenesis of most kidney
diseases from acute to chronic stages; however, diabetic nephropathy was not considered …

MicroRNA-29b inhibits diabetic nephropathy in db/db mice

HY Chen, X Zhong, XR Huang, XM Meng, Y You… - Molecular Therapy, 2014 - cell.com
Inflammation and its consequent fibrosis are two main features of diabetic nephropathy
(DN), but target therapy on these processes for DN remains yet ineffective. We report here …

[HTML][HTML] Diabetic complications and dysregulated innate immunity

DT Graves, RA Kayal - Frontiers in bioscience: a journal and virtual …, 2008 - ncbi.nlm.nih.gov
Diabetes mellitus is a metabolic disorder that leads to the development of a number of
complications. The etiology of each diabetic complication is undoubtedly multifactorial. We …

Recent advances on the roles of NO in cancer and chronic inflammatory disorders

JR Kanwar, RK Kanwar, H Burrow… - Current medicinal …, 2009 - ingentaconnect.com
Nitric oxide (NO) is a short-life molecule produced by the enzyme known as the nitric oxide
synthase (NOS), in a reaction that converts arginine and oxygen into citrulline and NO …

Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression

AA Alhaider, HM Korashy, MM Sayed-Ahmed… - Chemico-biological …, 2011 - Elsevier
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting
from defects in insulin secretion and/or action. One of the most important complications of …

Role of inflammation in diabetic nephropathy

O Lenz, A Fornoni, A Ijaz, T Tejada - Current diabetes reviews, 2008 - ingentaconnect.com
Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD).
Although the pathogenesis of DN is multifactorial, local inflammatory stress may result from …

[HTML][HTML] Therapeutic potential of pro-resolving mediators in diabetic kidney disease

T Vartak, C Godson, E Brennan - Advanced drug delivery reviews, 2021 - Elsevier
Renal microvascular disease associated with diabetes [Diabetic kidney disease-DKD] is the
leading cause of chronic kidney disease. In DKD, glomerular basement membrane …